Point in time view as at 25/05/2018.
Data Protection Act 2018, Cross Heading: Controlled Drugs (Supervision of Management and Use) Regulations 2013 (S.I. 2013/373) is up to date with all changes known to be in force on or before 01 March 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
378(1)Regulation 20 of the Controlled Drugs (Supervision of Management and Use) Regulations 2013 (information management) is amended as follows.U.K.
(2)For paragraph (4) substitute—
“(4)Where a CDAO, a responsible body or someone acting on their behalf is permitted to share information which includes personal data by virtue of a function under these Regulations, it is to be assumed for the purposes of paragraph 5(2) of Schedule 2 to the Data Protection Act 2018 and paragraph 3(2) of Schedule 11 to that Act (exemptions from certain provisions of the data protection legislation: disclosures required by law) that the disclosure is required by this regulation.”
(3)In paragraph (5), after “enactment” insert “ or the GDPR ”.
(4)After paragraph (6) insert—
“(7)In this regulation, “the GDPR”, “personal data” and references to Schedule 2 to the Data Protection Act 2018 have the same meaning as in Parts 5 to 7 of that Act (see section 3(2), (10), (11) and (14) of that Act).”
Commencement Information
I1Sch. 19 para. 378 in force at 25.5.2018 by S.I. 2018/625, reg. 2(1)(g)
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
